Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2026
Systemic Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer: ASCO Living Guideline, Version 2026.1.4.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Taplin Mary-Ellen, Parikh Rahul A, Rumble R Bryan, Naqvi Syed Arsalan Ahmed, Nahhat Fouad, Dias Mariane Fontes, Hope Thomas A, He Huan, Hotte Sebastien J, Emamekhoo Hamid, Murad M Hassan, Celano Paul, Kungel Terry M, Hentzen Steve, Marzalik Jacob S, Serzan Michael Thomas, Riaz Irbaz B
Аннотация
[Box: see text]Living guidelines are developed for selected topic areas with rapidly evolving evidence that drives frequent change in recommended clinical practice. Living guidelines are updated on a regular schedule by a standing expert panel that systematically reviews the health literature on a continuous basis, as described in the ASCO Guidelines Methodology Manual. ASCO Living Guidelines follow the ASCO Conflict of Interest Policy Implementation for Clinical Practice Guidelines. Living Guidelines and updates are not intended to substitute for independent professional judgment of the treating clinician and do not account for individual variation among patients. See appendix for disclaimers and other important information (Appendix 1 and Appendix 2, online only). Updates are published regularly and can be found on the ASCO Publications website.